Drawing for ALGIPHARMA

USPTO serial 79198826

ALGIPHARMA

Reviewed by CopyMark Law Group

Reg. 5343262Status 709
Filing date
Status date
Registration date
Nov 28, 2017
Examiner
MIDDLETON, BERNICE L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALGIPHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparation for the treatment and prevention of microbial biofilm infections, and to normalize stagnant and viscous mucus for the treatment of pulmonary diseases, namely, cystic fibrosis and COPD, medical preparations for the treatment of infected wounds and ulcers, and veterinary preparations for biofilm infections, namely, mastitis and woundsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 17, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Apr 30, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 30, 2025INPCINVALIDATION PROCESSED—
Mar 7, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 14, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 14, 2024C71TCANCELLED SECTION 71—
May 4, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 15, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 15, 2018FIMPFINAL DISPOSITION PROCESSED—
Feb 28, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 28, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 12, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 23, 2017NPUBNOTICE OF PUBLICATION—
Aug 9, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 4, 2017CNEAEXAMINERS AMENDMENT MAILED—
Aug 3, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Aug 3, 2017ALIEASSIGNED TO LIE—
Aug 3, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 12, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 12, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 12, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 3, 2017RFNTREFUSAL PROCESSED BY IB—
Jan 13, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 13, 2017RFRRREFUSAL PROCESSED BY MPU—
Jan 5, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 4, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 31, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 27, 2016DOCKASSIGNED TO EXAMINER—
Dec 27, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 22, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance